Mutation of p16, p21 or cyclin dependent kinase 4 is rare in acute lymphoblastic leukaemia

This publication has 28 references indexed in Scilit:

• Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas
  Blood, 1995
• Apolipoprotein E2/E3/E4 genotyping with agarose gels
  Clinical Chemistry, 1995
• Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
  Genes & Development, 1994
• Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
  Nature Genetics, 1994
• pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
  Nature, 1994
• A cell cycle-regulated inhibitor of cyclin-dependent kinases.
  Proceedings of the National Academy of Sciences, 1994
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
  Cell, 1993
• WAF1, a potential mediator of p53 tumor suppression
  Cell, 1993
• p53 Mutations in Human Cancers
  Science, 1991
• Lymphoblastic Leukemia with Lymphomatous Features Associated with Abnormalities of the Short Arm of Chromosome 9
  New England Journal of Medicine, 1985